Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Takara Co., Ltd., commonly referred to as Takara, is a prominent Japanese company specialising in pharmaceutical preparation manufacturing. Headquartered in Japan, the firm operates across key regions, serving the global healthcare and biotechnology sectors. Established in 1954, Takara has a long-standing history of innovation within the pharmaceutical industry, with notable milestones in product development and manufacturing excellence.
The company's core offerings include high-quality pharmaceutical preparations, biotechnological products, and laboratory reagents, distinguished by their precision and reliability. Takara’s commitment to advancing medical research and healthcare solutions has positioned it as a trusted leader in the industry. With a strong market presence and a reputation for quality, Takara continues to contribute significantly to pharmaceutical and biotech advancements worldwide.
-9 vs industry average
Takara’s score of 33 is lower than 45% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Takara, a Pharmaceutical Preparation Manufacturing company with its HQ in JP, reported Scope 1 and 2 emissions of approximately 14,182,000 kg CO2e in 2025. This figure is slightly lower than the 14,211,000 kg CO2e reported in 2024 and the 15,692,000 kg CO2e reported in 2023. Looking further back, their Scope 1 and 2 emissions were around 14,253,000 kg CO2e in 2022, 12,836,000 kg CO2e in 2021, 10,892,000 kg CO2e in 2020, and 13,188,000 kg CO2e in 2019. These emissions data are cascaded from the parent company, Takara Bio Inc.
Takara aims to reduce its emissions intensity by 50% from fiscal 2019 levels by fiscal 2026. This target covers all emission scopes. It is important to note that Scope 3 emissions data, particularly for purchased goods and services, is currently missing from their disclosures.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more